Alivus Life

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE03Q201024
NSEID: ALIVUS
BSEID: 543322
View on NSE | View on BSE

INR

906.90

-2.7 (-0.3%)

BSENSE

Mar 05

BSE+NSE Vol: 28.23 k

{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "906.90",
    "chg": -2.7,
    "chgp": "-0.3%",
    "dir": -1,
    "prev_price": "909.60",
    "mcapval": "11,170.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE03Q201024",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": "28.23 k",
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3850320",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlivusLifeScien_mojoScore_3850320.png",
        "date": "2026-02-23 10:11:12",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3850328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlivusLifeScien_mojoScore_3850328.png",
        "date": "2026-02-22 10:10:41",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Why is Alivus Life Sciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-sciences-ltd-fallingrising-3847576",
        "imagepath": "",
        "date": "2026-02-20 01:11:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Alivus Life Sciences has experienced a modest downward trend over the past week, with the stock falling 3.16% compared to the Sensex’s 1.41% decline. Year-to-date, the stock is down 3.04%, closely mirroring the broader market’s 3.19% fall. Notably, over the last year, the stock has underperformed significantly, delivering a negative return of 12.03% while the Sensex gained 8.64%. However, the longer-term performance remains robust, with a three-year return of 132.48%, substantially outpacing the Sensex’s 35.24% gain.</p>\n<p>Despite the recent weakness, the stock did reach an intraday high of ₹917.6, up 2.05%, indicating some buying interest during the session. Nevertheless, the overall trend remains bearish as the share price is tradin..."
      },
      {
        "title": "Alivus Life Sciences Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-valuation-shifts-signal-renewed-price-attractiveness-3846305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlivusLifeScien_valuationdot_3846305.png",
        "date": "2026-02-19 08:02:18",
        "description": "Alivus Life Sciences Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven by improved price-to-earnings and price-to-book ratios relative to its historical averages and peer group. This change has prompted an upgrade in its Mojo Grade from Sell to Hold, reflecting a more favourable outlook amid a challenging pharmaceutical sector backdrop."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3832553",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AlivusLifeScien_mojoScore_3832553.png",
        "date": "2026-02-11 10:11:38",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 February 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-3812411",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_mojoScore_3812411.png",
        "date": "2026-01-31 10:10:48",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3806750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_technicaldot_3806750.png",
        "date": "2026-01-28 08:00:36",
        "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical parameters, signalling a nuanced change in price momentum. While some indicators suggest mild bullishness, others remain bearish, reflecting a complex outlook for investors in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-3805009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AlivusLifeScien_technicaldot_3805009.png",
        "date": "2026-01-27 08:03:19",
        "description": "Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest day gain of 1.53%, the stock’s broader technical landscape reveals a complex interplay of bullish and bearish signals, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Alivus Life Sciences Ltd Gains 0.20%: 4 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-gains-020-4-key-factors-driving-the-week-3803196",
        "imagepath": "",
        "date": "2026-01-24 11:03:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 19:</strong> Technical downgrade triggers bearish momentum</p>\n                    <p><strong>Jan 21:</strong> Mixed technical signals amid modest price decline</p>\n                    <p><strong>Jan 22:</strong> Quarterly results announced showing strong profit growth</p>\n                    <p><strong>Jan 23:</strong> Stock rallies 2.36% on strong quarterly performance</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.870.30</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.882.1..."
      }
    ],
    "total": 260,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (SEBI Listing Regulations)",
      "datetime": "25-Feb-2026",
      "details": "Kindly refer attachment.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 - Updates",
      "datetime": "16-Feb-2026",
      "details": "Kindly refer the enclosed attachment.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "Kindly refer enclosed attachment.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 25",
          "dt": "2025-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alivus Life Sciences Ltd is Rated Hold

2026-02-23 10:11:12

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 23 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-02-22 10:10:41

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Why is Alivus Life Sciences Ltd falling/rising?

2026-02-20 01:11:18

Recent Price Movement and Market Context

Alivus Life Sciences has experienced a modest downward trend over the past week, with the stock falling 3.16% compared to the Sensex’s 1.41% decline. Year-to-date, the stock is down 3.04%, closely mirroring the broader market’s 3.19% fall. Notably, over the last year, the stock has underperformed significantly, delivering a negative return of 12.03% while the Sensex gained 8.64%. However, the longer-term performance remains robust, with a three-year return of 132.48%, substantially outpacing the Sensex’s 35.24% gain.

Despite the recent weakness, the stock did reach an intraday high of ₹917.6, up 2.05%, indicating some buying interest during the session. Nevertheless, the overall trend remains bearish as the share price is tradin...

Read full news article

Alivus Life Sciences Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-02-19 08:02:18

Alivus Life Sciences Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, driven by improved price-to-earnings and price-to-book ratios relative to its historical averages and peer group. This change has prompted an upgrade in its Mojo Grade from Sell to Hold, reflecting a more favourable outlook amid a challenging pharmaceutical sector backdrop.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-02-11 10:11:38

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Alivus Life Sciences Ltd is Rated Hold

2026-01-31 10:10:48

Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 21 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-28 08:00:36

Alivus Life Sciences Ltd has experienced a notable shift in its technical parameters, signalling a nuanced change in price momentum. While some indicators suggest mild bullishness, others remain bearish, reflecting a complex outlook for investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

Alivus Life Sciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-01-27 08:03:19

Alivus Life Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a modest day gain of 1.53%, the stock’s broader technical landscape reveals a complex interplay of bullish and bearish signals, prompting a reassessment of its near-term outlook within the Pharmaceuticals & Biotechnology sector.